-
1
-
-
0025779484
-
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
-
Wolf P.A., Abbott R.D., and Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 22 (1991) 983-988
-
(1991)
Stroke
, vol.22
, pp. 983-988
-
-
Wolf, P.A.1
Abbott, R.D.2
Kannel, W.B.3
-
2
-
-
0029029056
-
The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba follow-up study
-
Krahn A.D., Mnafreda J., Tate R.B., Mathewson F.A., and Cuddy T.E. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba follow-up study. Am J Med 98 (1995) 476-484
-
(1995)
Am J Med
, vol.98
, pp. 476-484
-
-
Krahn, A.D.1
Mnafreda, J.2
Tate, R.B.3
Mathewson, F.A.4
Cuddy, T.E.5
-
3
-
-
0035854054
-
Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation
-
Gage B.F., Waterman A.D., Shannon W., Boechler M., Rich M.W., and Radford M.J. Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation. JAMA 285 (2001) 2864-2870
-
(2001)
JAMA
, vol.285
, pp. 2864-2870
-
-
Gage, B.F.1
Waterman, A.D.2
Shannon, W.3
Boechler, M.4
Rich, M.W.5
Radford, M.J.6
-
4
-
-
0024543543
-
Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complication in chronic atrial fibrillation: the Copenhagen AFSAK study
-
Petersen P., Boysen G., Godtfredsen J., Andersen E.D., and Andersen B. Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complication in chronic atrial fibrillation: the Copenhagen AFSAK study. Lancet 1 (1989) 175-179
-
(1989)
Lancet
, vol.1
, pp. 175-179
-
-
Petersen, P.1
Boysen, G.2
Godtfredsen, J.3
Andersen, E.D.4
Andersen, B.5
-
5
-
-
0025914693
-
Stroke prevention in atrial fibrillation: final results
-
The Stroke Prevention in Atrial Fibrillation Investigators
-
The Stroke Prevention in Atrial Fibrillation Investigators. Stroke prevention in atrial fibrillation: final results. Circulation 84 (1991) 527-539
-
(1991)
Circulation
, vol.84
, pp. 527-539
-
-
-
6
-
-
0025241137
-
The effect of low dose warfarin on the risk of stroke in nonrheumatic atrial fibrillation
-
The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators
-
The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low dose warfarin on the risk of stroke in nonrheumatic atrial fibrillation. N Engl J Med 323 (1990) 1505-1511
-
(1990)
N Engl J Med
, vol.323
, pp. 1505-1511
-
-
-
7
-
-
0025814587
-
Canadian atrial fibrillation anticoagulation (CAFA) study
-
CAFA Study Investigators
-
Connolly S.J., Laupacis A., Gent M., Roberts R.S., Cairns J.A., Joyner C., and CAFA Study Investigators. Canadian atrial fibrillation anticoagulation (CAFA) study. J Am Coll Cardiol 18 (1991) 349-355
-
(1991)
J Am Coll Cardiol
, vol.18
, pp. 349-355
-
-
Connolly, S.J.1
Laupacis, A.2
Gent, M.3
Roberts, R.S.4
Cairns, J.A.5
Joyner, C.6
-
8
-
-
0026478818
-
Warfarin in the prevention of stroke associated with non-rheumatic atrial fibrillation
-
Ezekowitz M.D., Bridgers S.L., James K.E., et al. Warfarin in the prevention of stroke associated with non-rheumatic atrial fibrillation. N Engl J Med 327 (1992) 1406-1412
-
(1992)
N Engl J Med
, vol.327
, pp. 1406-1412
-
-
Ezekowitz, M.D.1
Bridgers, S.L.2
James, K.E.3
-
9
-
-
0028244264
-
Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized control trials
-
Atrial Fibrillation Investigators
-
Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized control trials. Arch Intern Med 154 (1994) 1449-1457
-
(1994)
Arch Intern Med
, vol.154
, pp. 1449-1457
-
-
-
10
-
-
85007177383
-
Risk factors for thromboembolism during aspirin therapy in patients with atrial fibrillation: the stroke prevention in atrial fibrillation study
-
Stroke Prevention in Atrial Fibrillation Investigators
-
Stroke Prevention in Atrial Fibrillation Investigators. Risk factors for thromboembolism during aspirin therapy in patients with atrial fibrillation: the stroke prevention in atrial fibrillation study. J Stroke Cerebrovasc Dis 5 (1995) 147-157
-
(1995)
J Stroke Cerebrovasc Dis
, vol.5
, pp. 147-157
-
-
-
11
-
-
0027505093
-
Secondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor stroke
-
EAFT (European Atrial Fibrillation Trial) Study Group
-
EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor stroke. Lancet 342 (1993) 1255-1262
-
(1993)
Lancet
, vol.342
, pp. 1255-1262
-
-
-
12
-
-
0028106507
-
Prognostic implication of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation
-
Leung D.Y., Black I.W., Cranney G.B., Hopkins A.P., and Walsh W.F. Prognostic implication of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation. J Am Coll Cardiol 24 (1994) 755-762
-
(1994)
J Am Coll Cardiol
, vol.24
, pp. 755-762
-
-
Leung, D.Y.1
Black, I.W.2
Cranney, G.B.3
Hopkins, A.P.4
Walsh, W.F.5
-
13
-
-
25444442635
-
Utility of transesophageal echocardiography in identification of thrombogenic milieu in patients with atrial fibrillation (an ACUTE ancillary study)
-
Thambidorai S.K., Murray R.D., Parakh K., et al. Utility of transesophageal echocardiography in identification of thrombogenic milieu in patients with atrial fibrillation (an ACUTE ancillary study). Am J Cardiol 96 (2005) 935-941
-
(2005)
Am J Cardiol
, vol.96
, pp. 935-941
-
-
Thambidorai, S.K.1
Murray, R.D.2
Parakh, K.3
-
14
-
-
0031747445
-
Transesophageal echocardiographic correlates of clinical risk of thromboembolism in non valvular atrial fibrillation
-
Zabalgoitia M., Halperin J.L., Parce L.A., Blackshear J.L., Asinger R.W., and Hart R.G. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in non valvular atrial fibrillation. J Am Coll Cardiol 31 (1998) 1622-1626
-
(1998)
J Am Coll Cardiol
, vol.31
, pp. 1622-1626
-
-
Zabalgoitia, M.1
Halperin, J.L.2
Parce, L.A.3
Blackshear, J.L.4
Asinger, R.W.5
Hart, R.G.6
-
15
-
-
0034814620
-
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European Society of Cardiology committee for practice guidelines and policy conferences (committee to develop guidelines for the management of patients with atrial fibrillation)
-
Fuster V., Ryden L.E., Asinger R.W., et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European Society of Cardiology committee for practice guidelines and policy conferences (committee to develop guidelines for the management of patients with atrial fibrillation). J Am Coll Cardiol 38 (2001) 1231-1266
-
(2001)
J Am Coll Cardiol
, vol.38
, pp. 1231-1266
-
-
Fuster, V.1
Ryden, L.E.2
Asinger, R.W.3
|